Brain Neoplasms, Leukemia and Petrochemical Exposures
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of this study is to examine the association of exposure to air contaminants (PAH & VOC) emitted from the petrochemical industries, specific genetic polymorphisms (P4501A1 (MspI & exon 7) and GSTM1 & T1) of study subjects and their parents, and the risks of brain tumors and leukemia among children and youths in metropolitan Kaohsiung, southern Taiwan.
| Condition |
|---|
|
Leukemia Brain Neoplasm |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Observational Model: Natural History |
| Estimated Enrollment: | 1456 |
| Study Start Date: | August 2000 |
| Estimated Study Completion Date: | July 2005 |
Brain tumors and leukemia are the most common malignancies among children and adolescents in the U.S. Adequate information on the role of inherited genetic susceptibility and environmental exposures in the development of neoplasms in children and adolescents is lacking. In Taiwan, four large petrochemical industries are located in the Kaohsiung metropolitan area. These facilities are proximal to residential areas because of the high population density in the region. Data have shown that the concentrations of ambient polycyclic aromatic hydrocarbons (PAH) and volatile organic compounds (VOC) around the petrochemical industries are at least 10 and 2 times, respectively, higher than those in U.S. industrialized communities. Our preliminary case-control study in metropolitan Kaohsiung showed that young residents (under age 30) living within 3 kilometers of the vicinity of petrochemical industries have a 6.0 fold increase in brain neoplasms and a 2.9 fold increase in leukemia. The purpose of this proposal is to examine the association of exposure to air contaminants (PAH and VOC) emitted from the petrochemical industries, specific genetic polymorphisms (P4501A1 (MspI & exon 7) and GSTM1 &T1) from study subjects and their parents, and the risks of brain tumors and leukemia among children and youths in metropolitan Kaohsiung. Our hypothesis is that there is an increased risk of brain tumors and leukemia in patients with high cumulative exposure to these hazards, and that heritable polymorphisms in several genes modify this association. In addition to an independent association of environmental and genetic factors with brain neoplasms and leukemia, we hypothesize that there is greater risk associated with the presence of combined environmental exposure and the high risk genotype. Also, we will assess the role of parental genetic polymorphisms in the development of cancer in their siblings. This proposed study uses an environmental molecular epidemiologic approach, utilizing prospective enrollment of a cohort of brain tumor and leukemia subjects in a population-based case-control design. This proposal is responsive to the recommendation of the National Research Council that risk assessment and public health policy pay special attention to the protection of children.
Eligibility| Ages Eligible for Study: | up to 30 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Young population Less than 30 Resident of Kaohsiung metropolitan, Taiwan
Contacts and Locations| United States, Massachusetts | |
| Harvard School of Public Health | |
| Boston, Massachusetts, United States, 02115 | |
| Taiwan | |
| Kaohsiung Medical University | |
| Kaohsiung, Taiwan, 80708 | |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00042445 History of Changes |
| Other Study ID Numbers: | 9723-CP-001 |
| Study First Received: | July 30, 2002 |
| Last Updated: | September 1, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Environmental Health Sciences (NIEHS):
|
Neoplasm Petrochemical Leukemia Taiwan |
Additional relevant MeSH terms:
|
Brain Neoplasms Neoplasms Leukemia Central Nervous System Neoplasms Nervous System Neoplasms |
Neoplasms by Site Brain Diseases Central Nervous System Diseases Nervous System Diseases Neoplasms by Histologic Type |
ClinicalTrials.gov processed this record on May 23, 2013